Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 165
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01104870 | A Dose Response Study of UT-15C SR in Patients With Exercise-Induced Pulmonary Hypertension | ||
| NCT06425796 | Adiposity and Iron Requirements in Pregnancy | ||
| NCT03857841 | A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD | ||
| NCT02663895 | Safety and Efficacy of Oral Treprostinil in the Treatment of Calcinosis in Patients With Systemic Sclerosis | ||
| NCT06223009 | Phase 1 Healthy Volunteer Burn Therapy Study | ||
| NCT07037836 | Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia | ||
| NCT00887978 | Efficacy and Safety of Oral UT-15C Tablets to Treat Pulmonary Arterial Hypertension | ||
| NCT00067041 | Effects of Remodulin in Patients With Critical Limb Ischemia Following a Vein Bypass Graft | ||
| NCT01592045 | ch14.18 Pharmacokinetic Study in High-risk Neuroblastoma | ||
| NCT02693171 | Post-Marketing Assessment of Immunogenicity and Safety of Unituxin® in High-Risk Neuroblastoma Patients | ||
| NCT07224763 | Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD | ||
| NCT02279160 | Safety and Efficacy of APD811 in Pulmonary Arterial Hypertension | ||
| NCT02999906 | Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension | ||
| NCT01934582 | A Pharmacokinetic Substudy of the TDE-PH-304 Protocol | ||
| NCT01560624 | Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy | ||
| NCT00963001 | Effect of Food on the Pharmacokinetics of Oral Treprostinil | ||
| NCT01566877 | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AVI-7288 in Healthy Adult Volunteers | ||
| NCT03367312 | Assessing Response to Inhaled Prostacyclin With Hyperpolarized Xe MRI | ||
| NCT04708782 | Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis | ||
| NCT02847260 | Safety and Tolerability of Rapid Dose Titration of Subcutaneous Remodulin® Therapy in PAH Subjects (RAPID) | ||
| NCT01172496 | A Bioavailability Study Comparing Treprostinil Diethanolamine Oral Tablets and Oral Solution in Healthy Volunteers | ||
| NCT04868292 | Study to Assess the Intrapulmonary Pharmacokinetics of SPR206 in Healthy Volunteers | ||
| NCT06964009 | DT2216 + Paclitaxel in Platinum-Resistant Ovarian Cancer | ||
| NCT00147199 | Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) | ||
| NCT04090866 | Cardiac Metabolic Remodeling After Pulmonary Vasodilator Therapy in Pulmonary Arterial Hypertension: A Pilot Study | ||
| NCT03012646 | Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD | ||
| NCT00439946 | Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAH | ||
| NCT02074449 | Study Of Right Ventricular Performance In PAH Patients Treated With Rapid Dose Treprostinil (Remodulin) | ||
| NCT03055234 | Study to Evaluate Efficacy and Safety of Oral Treprostinil in Subjects With Pulmonary Hypertension (PH) Associated With Sickle Cell Disease (SCD) | ||
| NCT01266265 | Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies | ||
| NCT03950739 | Open-label, Clinical Study to Evaluate the Safety and Tolerability of TreT in Subjects With PAH Currently Using Tyvaso | ||
| NCT06911632 | Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension | ||
| NCT03683186 | A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension | ||
| NCT00741819 | Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects | ||
| NCT01588405 | Remodulin® to Oral Treprostinil Transition | ||
| NCT02276872 | Safety, Tolerability, and Pharmacokinetics of Oral Treprostinil in Pediatric PAH Patients Aged 7 to 17 Years | ||
| NCT05943535 | Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) | ||
| NCT06450041 | NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial | ||
| NCT02318758 | Pharmacokinetic Interaction of Oral Treprostinil and Ethanol in Healthy Volunteers | ||
| NCT06878560 | Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD | ||
| NCT00969722 | A Study of MAb-3F8 Plus Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) Versus 13-cis-Retinoic Acid (RA) Plus GM-CSF in Primary Refractory Neuroblastoma Patients | ||
| NCT01131845 | The Effect of Renal Impairment on the Pharmacokinetics of Oral Treprostinil | ||
| NCT03888365 | Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAH | ||
| NCT01560637 | An Open-Label, Long-Term Study of Oral Treprostinil in Subjects With Pulmonary Arterial Hypertension | ||
| NCT02360345 | Phase I Trial of ONX-0801 Once Weekly or Alternate Weekly | ||
| NCT02370095 | Treprostinil Sodium Inhalation for Patients At High Risk for ARDS | ||
| NCT02261883 | Remodulin as Add-on Therapy for the Treatment of Persistent Pulmonary Hypertension of the Newborn | ||
| NCT00325442 | FREEDOM-C: Oral Treprostinil in Combination With an Endothelin Receptor Antagonist (ERA) and/or a Phosphodiesterase-5 (PDE-5) Inhibitor for the Treatment of Pulmonary Arterial Hypertension (PAH) | ||
| NCT05735249 | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Oral ARN-75039 in Healthy Adult Subjects | ||
| NCT04050449 | Assess Therapeutic Efficacy and Emergence of HIV Drug Resistance Following Initiation of TLD |
